mTOR cascade activation distinguishes tubers from focal cortical dysplasia

Balloon cells (BCs) in focal cortical dysplasia (FCD) and giant cells (GCs) in tubers of the tuberous sclerosis complex (TSC) share phenotypic similarities. TSC1 or TSC2 gene mutations in TSC lead to mTOR pathway activation and p70S6kinase (phospho‐S6K) and ribosomal S6 (phospho‐S6) protein phosphorylation. Phospho‐S6K, phospho‐S6, and phospho‐S6K–activated proteins phospho‐STAT3 and phospho‐4EBP1 were detected immunohistochemically in GCs, whereas only phospho‐S6 was observed in BCs. Expression of four candidate gene families (cell signaling, cell adhesion, growth factor/receptor, and transcription factor mRNAs) was assayed in single, microdissected phospho‐S6–immunolabeled BCs and GCs as a strategy to define whether BCs and GCs exhibit differential transcriptional profiles. Among 60 genes, differential expression of 24 mRNAs distinguished BCs from GCs and only 4 genes showed similar expression profiles between BCs and GCs. Tuberin mRNA levels were reduced in GCs from TSC patients with TSC2 gene mutations but were unchanged in BCs. Phospho‐S6K, ‐S6, ‐STAT3, and ‐4EBP1 expression in GCs reflects loss of hamartin‐tuberin–mediated mTOR pathway inhibition. Phospho‐S6 expression alone in BCs does not support mTOR cascade activation in FCD. Differential gene expression profiles in BCs and GCs supports the hypothesis that these cell types derive by distinct pathogenic mechanisms. Ann Neurol 2004

[1]  M A Falconer,et al.  Focal dysplasia of the cerebral cortex in epilepsy , 1971, Journal of neurology, neurosurgery, and psychiatry.

[2]  Frederick Andermann,et al.  Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results , 1995, Annals of neurology.

[3]  P. Mischel,et al.  Cerebral Cortical Dysplasia Associated with Pediatric Epilepsy. Review of Neuropathologic Features and Proposal for a Grading System , 1995, Journal of neuropathology and experimental neurology.

[4]  J. Trojanowski,et al.  Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  V. Jay,et al.  Evidence of abnormal differentiation in giant cells of tuberous sclerosis. , 1997, Pediatric neurology.

[6]  J. Trojanowski,et al.  Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity , 1997, Acta Neuropathologica.

[7]  H. Northrup,et al.  Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria , 1998, Journal of child neurology.

[8]  J. Weingarten,et al.  Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques , 1999, Annals of neurology.

[9]  M. Duchowny,et al.  Topical Review: Clinical Spectrum of Cortical Dysplasia in Childhood: Diagnosis and Treatment Issues , 1999, Journal of child neurology.

[10]  P. Crino,et al.  Preparation of cDNA from single cells and subcellular regions. , 1999, Methods in enzymology.

[11]  S. Yilmaz,et al.  Dizygotic twins with schizencephaly and focal cortical dysplasia. , 2000, AJNR. American journal of neuroradiology.

[12]  P. Crino,et al.  Traumatic Brain Injury Alters the Molecular Fingerprint of TUNEL-Positive Cortical Neurons In Vivo: A Single-Cell Analysis , 2000, The Journal of Neuroscience.

[13]  B. Scheithauer,et al.  Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. , 2001, The American journal of pathology.

[14]  P. Crino,et al.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia , 2001, Neurology.

[15]  A. J. Barkovich,et al.  Classification system for malformations of cortical development , 2001, Neurology.

[16]  S F Berkovic,et al.  Causes of epilepsies: Insights from discordant monozygous twins , 2001, Annals of neurology.

[17]  M. Flaig,et al.  Loss of tuberin, the tuberous‐sclerosis‐complex‐2 gene product is associated with angiogenesis , 2001, Journal of cutaneous pathology.

[18]  D. Kwiatkowski,et al.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.

[19]  B. Scheithauer,et al.  Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers , 2001, Annals of neurology.

[20]  L. Aicher,et al.  Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.

[21]  K. Unsicker,et al.  TGF-beta and the regulation of neuron survival and death. , 2002, Journal of physiology, Paris.

[22]  C. Elger,et al.  Focal cortical dysplasia of Taylor's balloon cell type: Mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis , 2002, Annals of neurology.

[23]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[24]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Alessi,et al.  TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.

[26]  O. Hino,et al.  Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling , 2002, Nature Cell Biology.

[27]  P. Crino,et al.  Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. , 2002, Virology.

[28]  P. Crino,et al.  Neurodevelopmental Disorders as a Cause of Seizures: Neuropathologic, Genetic, and Mechanistic Considerations , 2002, Brain pathology.

[29]  M. Mizuguchi,et al.  Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia , 2002, Acta Neuropathologica.

[30]  J. Olivo-Marin,et al.  Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast , 2002, Nature Cell Biology.

[31]  Hongbing Zhang,et al.  Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway , 2002, Molecular and Cellular Neuroscience.

[32]  K. Unsicker,et al.  TGF-β and the regulation of neuron survival and death , 2002, Journal of Physiology-Paris.

[33]  P. Crino,et al.  Single cell lineage analysis in human focal cortical dysplasia. , 2003, Cerebral cortex.

[34]  Hongbing Zhang,et al.  Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma , 2003, The Lancet.

[35]  M. Baybis,et al.  Expression of ICAM-1, TNF-α, NFκB, and MAP kinase in tubers of the tuberous sclerosis complex , 2003, Neurobiology of Disease.

[36]  B. Scheithauer,et al.  Markers of cellular proliferation are expressed in cortical tubers , 2003, Annals of neurology.

[37]  Hongbing Zhang,et al.  Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. , 2003, The Journal of clinical investigation.

[38]  V. Poukens,et al.  Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia , 1994, Acta Neuropathologica.